Skip to content

APOTHEEK BROEKAERT

Active Private limited companyfounded 2009active for 16 yearsZwijnaardsesteenweg 266, 9000 GhentKBO/BCE: BE 0821.390.951

Lifetime

16 annual accounts with figures on one time axis
peak of €154,389 in 2010
€47,761▲ 32.8%
peak of €56,283 in 2010
€27,454▲ 42.9%
peak of €416,757 in 2025
€416,757▲ 7.1%
€127,531▲ 42.3%
Board1 name since 2021
1 director
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Gross margin from €35,977 to €47,761Result from €19,206 to €27,454Debts from €89,606 to €127,531

Key points

from the 2025 annual accounts

Equity

€416,757 ▲ 7.1%

APOTHEEK BROEKAERT has made a profit in every financial year since 2010.

Filings

16 annual accounts 61 days
AprilJune31 JulyOctober2010201520202025

Latest accounts filed late: after the legal deadline.

Position in the sector

€416,757

More equity than 94% of companies in retail trade. Sector median €40,791 · 25,439 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as APOTHEEK BROEKAERT has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for APOTHEEK BROEKAERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0821390951
changes role from manager to director General meeting of 30-12-2023 · Gazette deed
Publication in the Belgian Official Gazette Capital €18,000, annual accounts 2010 · Gazette deed
Incorporation published on 22-12-2009 · Gazette deed
All 25 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK BROEKAERT Ghent €544,288 €47,761 76.6% -
Farmadec Asse €554,731 €45,948 29.5% -
PHARMACIE DU HORLOZ Saint-Nicolas €513,078 €50,252 27.5% -
VRB FARMA Mechelen €551,620 €46,476 63.4% -
Apotheek Schockaert M. Dendermonde €473,175 €47,103 25.4% -
BEIRNAERT VG Destelbergen €584,335 €58,216 23.7% -
HERMELIZE Dilbeek €473,074 €45,028 -14.7% -

These companies have the same main activity as APOTHEEK BROEKAERT: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €473,000 and €584,000, founded between 2008 and 2011.

Official details

Source: KBO
Status
Active since 11-12-2009Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.183.787.6259000 Ghent, since 11-12-2009
Financial year end
31 December
Peppol
Reachable since 21-10-2026
Company details

Annual accounts 2025

≈ €220,000estimated
€544,288▲ 13.7%
Filing
Filed on 30-09-2026
Financials

Insights on APOTHEEK BROEKAERT

APOTHEEK BROEKAERT files the micro format. That format states no turnover. The gross margin fell from €154,389 in 2010 to €47,761 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK BROEKAERT

What is the company number of APOTHEEK BROEKAERT?
The company number of APOTHEEK BROEKAERT is 0821.390.951. The VAT number is the same number with BE in front: BE 0821.390.951.
Where is APOTHEEK BROEKAERT based?
The registered office is at Zwijnaardsesteenweg 266, 9000 Ghent.Company details
What does APOTHEEK BROEKAERT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK BROEKAERT?
APOTHEEK BROEKAERT is a private limited company (BV).
When was APOTHEEK BROEKAERT founded?
APOTHEEK BROEKAERT was founded on 11-12-2009.
Is APOTHEEK BROEKAERT still active?
Yes, APOTHEEK BROEKAERT is an active enterprise in the KBO register.
Which joint committee does APOTHEEK BROEKAERT fall under?
In its 2025 annual accounts, APOTHEEK BROEKAERT states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK BROEKAERT?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €47,761 and 56 comparable companies (NACE 477). It probably lies between €120,000 and €390,000.Financials
Is APOTHEEK BROEKAERT profitable?
In financial year 2025, APOTHEEK BROEKAERT made a profit of €27,454.
Where can I find the annual accounts of APOTHEEK BROEKAERT?
APOTHEEK BROEKAERT filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK BROEKAERT due?
APOTHEEK BROEKAERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.